Literature DB >> 12006491

Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.

Emma Langley1, Mark Pearson, Mario Faretta, Uta-Maria Bauer, Roy A Frye, Saverio Minucci, Pier Giuseppe Pelicci, Tony Kouzarides.   

Abstract

The yeast Sir2 protein mediates chromatin silencing through an intrinsic NAD-dependent histone deacetylase activity. Sir2 is a conserved protein and was recently shown to regulate lifespan extension both in budding yeast and worms. Here, we show that SIRT1, the human Sir2 homolog, is recruited to the promyelocytic leukemia protein (PML) nuclear bodies of mammalian cells upon overexpression of either PML or oncogenic Ras (Ha-rasV12). SIRT1 binds and deacetylates p53, a component of PML nuclear bodies, and it can repress p53-mediated transactivation. Moreover, we show that SIRT1 and p53 co-localize in nuclear bodies upon PML upregulation. When overexpressed in primary mouse embryo fibroblasts (MEFs), SIRT1 antagonizes PML-induced acetylation of p53 and rescues PML-mediated premature cellular senescence. Taken together, our data establish the SIRT1 deacetylase as a novel negative regulator of p53 function capable of modulating cellular senescence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006491      PMCID: PMC126010          DOI: 10.1093/emboj/21.10.2383

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  86 in total

Review 1.  Nuclear bodies: multifaceted subdomains of the interchromatin space.

Authors:  A G Matera
Journal:  Trends Cell Biol       Date:  1999-08       Impact factor: 20.808

Review 2.  The nucleolus: nucleolar space for RENT.

Authors:  M M Cockell; S M Gasser
Journal:  Curr Biol       Date:  1999 Jul 29-Aug 12       Impact factor: 10.834

Review 3.  Sir-Ku-itous routes to make ends meet.

Authors:  J E Haber
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

Review 4.  The PML nuclear bodies: actors or extras?

Authors:  J S Seeler; A Dejean
Journal:  Curr Opin Genet Dev       Date:  1999-06       Impact factor: 5.578

Review 5.  Histone acetylases and deacetylases in cell proliferation.

Authors:  T Kouzarides
Journal:  Curr Opin Genet Dev       Date:  1999-02       Impact factor: 5.578

Review 6.  Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.

Authors:  A Melnick; J D Licht
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

7.  Characterization of a human gene with sequence homology to Saccharomyces cerevisiae SIR2.

Authors:  G Afshar; J P Murnane
Journal:  Gene       Date:  1999-06-24       Impact factor: 3.688

8.  Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.

Authors:  R A Frye
Journal:  Biochem Biophys Res Commun       Date:  1999-06-24       Impact factor: 3.575

9.  The conserved core of a human SIR2 homologue functions in yeast silencing.

Authors:  J M Sherman; E M Stone; L L Freeman-Cook; C B Brachmann; J D Boeke; L Pillus
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

10.  Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.

Authors:  V Doucas; M Tini; D A Egan; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

View more
  312 in total

1.  Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci.

Authors:  Hong Zhang; Kuang-Hung Pan; Stanley N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

2.  Histone Deacetylase SIRT1 Targets Plk2 to Regulate Centriole Duplication.

Authors:  Hongbo Ling; Lirong Peng; Jianbo Wang; Raneen Rahhal; Edward Seto
Journal:  Cell Rep       Date:  2018-12-04       Impact factor: 9.423

3.  Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.

Authors:  Minqing Wu; Weidong Wei; Xiangsheng Xiao; Jiaoli Guo; Xinhua Xie; Laisheng Li; Yanan Kong; Ning Lv; Weihua Jia; Yin Zhang; Xiaoming Xie
Journal:  Med Oncol       Date:  2012-06-04       Impact factor: 3.064

4.  A chromosomal SIR2 homologue with both histone NAD-dependent ADP-ribosyltransferase and deacetylase activities is involved in DNA repair in Trypanosoma brucei.

Authors:  José A García-Salcedo; Purificación Gijón; Derek P Nolan; Patricia Tebabi; Etienne Pays
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

5.  Dominant-negative Dmp53 extends life span through the dTOR pathway in D. melanogaster.

Authors:  Johannes H Bauer; Chengyi Chang; Gina Bae; Siti Nur Sarah Morris; Stephen L Helfand
Journal:  Mech Ageing Dev       Date:  2010-02-01       Impact factor: 5.432

Review 6.  p53, oxidative stress, and aging.

Authors:  Dongping Liu; Yang Xu
Journal:  Antioxid Redox Signal       Date:  2011-02-07       Impact factor: 8.401

7.  SIRT1 stabilizes PML promoting its sumoylation.

Authors:  M Campagna; D Herranz; M A Garcia; L Marcos-Villar; J González-Santamaría; P Gallego; S Gutierrez; M Collado; M Serrano; M Esteban; C Rivas
Journal:  Cell Death Differ       Date:  2010-06-25       Impact factor: 15.828

8.  Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury.

Authors:  Tim West; Madeliene Atzeva; David M Holtzman
Journal:  Dev Neurosci       Date:  2007       Impact factor: 2.984

9.  Autoregulation of mouse histone deacetylase 1 expression.

Authors:  Bernd Schuettengruber; Elisabeth Simboeck; Harald Khier; Christian Seiser
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

Authors:  Brittney Jung-Hynes; Minakshi Nihal; Weixiong Zhong; Nihal Ahmad
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.